Tampa General Hospital’s Post

📣 Reality Check: DTX Investment Landscape, Still Hot or Cooling Down? Join our panel of #HealthtechLeaders as they discuss: ·  How do investors assess the current investment landscape for DTx startups, and what key factors influence investment decisions in this competitive environment ·  What specific strategies and criteria do investors look for in DTx startups to determine their readiness for investment rounds ·  With a sea of startups vying for attention, how can a company distinguish its pitch   🎙 Hear from: ·  Andy Molnar, CEO, Digital Therapeutics Alliance ·  Dominick Kennerson, SVP, HealthTech, HSBC Innovation Banking ·  Shamik J Parekh, Investor, Octopus Ventures ·  Ingrid Teigland Akay, Managing Partner, Hadean Ventures ·  Erki Mölder, Managing Partner, Verge HealthTech Fund ·  Josep Ll. Sanfeliu, Managing Partner, Asabys Partners Find out more: https://lnkd.in/eaQvGRNm #LSXWorld 

How should European Medtech startups approach entering the US market? In this clip, Murielle Thinard McLane, Managing Partner at Intuitive Ventures, shares her observations on how companies are tackling this and provides guidance for those aiming to break into the US market. Hear more from both US and European based investors as they discuss European and US investment dynamics in the #LSIEurope23 panel, ‘Transatlantic Investment & Innovation: Juxtaposing European & US Dynamics for Investing in, Building, & Scaling Companies.’ Featured Panelists: • Mano Iyer, Partner, Sofinnova Partners (Moderator) • Sascha Berger, General Partner at TVM Capital Life Science • Janke Dittmer, General Partner, Gilde Healthcare • Murielle Thinard McLane, Managing Partner, Intuitive Ventures • Vijay Barathan, MD, Partner, Optum Ventures The full panel is available on our website and YouTube channel. Registration and applications to present are open for LSI Europe ‘24 this September 16th - 20th at the Penha Longa Resort, in Portugal. Secure your spot today to ensure you get the best rate and secure a hotel room onsite.

Not only will there be great coverage of #DigitalHealth solutions for #PatientCare but there will be excellent sessions for #entrepreneurs, #investors and #innovators in the #healthcare #startup space. Can’t wait for this conference. #HRX2023. Heart Rhythm Society, HRX 2023, Jag Singh, Sana Al-Khatib, Martha Gulati, Janet K. Han, Andrea Russo, Nishaki Mehta

Meet Vincent Lepreux from Our Innovation Fund at BioTechX Europe 2023 starting from tomorrow in Basel, and join Nicolas Stalder for the Investor Panel Discussion “Navigating the HealthTech Investment Landscape: an overview of different models” on day 3! They look forward to meeting with #entrepreneurs in the medtech and digital health sectors and connect with fellow investors. See you there! 👋 #digitalhealth #venturecapital #startups #innovation #healthcare 

Hot 🔥 off the press 📰 New funds are on their way to the Aussie & APAC #healthtech #deeptech ecosystems! Here's the quick wrap 👀 on Synthesis Capital... Focus 🎯 Deep health tech, led by industry experts Investment Range 💸 From pre-Seed to Series A+ stages in Australia and the Asia Pacific Partnerships 🤝 Exclusive collaboration with the MedTech Actuator for deal flow Risk Management ⚖ Integration of capital with milestone-based investment scaling Fund Size 🤑 Targeting $50M+, scalable to $100M+ (initial close at $10-20M) Returns 📊 Targeting an IRR of 25%; co-investment opportunities for LPs Team 👯 Vishaal Kishore - Managing Partner Buzz Palmer - Investment Partner, Venture Development Makenzie Thomas - Portfolio Manager Tom Bentley - Investment Partner, Ecosystems & Impact Tim Macready - Lead, Investment Governance Sophy Tang Chui Na - Investment Analyst Article written by: Will Richards https://lnkd.in/gH7UMU8t

“It's better to focus on how to generate cash instead of how to raise funding”. Yesterday, at Health Tech Forward, Ritesh Patel and Julien de Salaberry did a fantastic overview of the digital health investment landscape in 2023. Short, sweet, and packed with pearls of wisdom for startups – this session was a gem! Stay tuned for the detailed report on core investors in digital health, prepared by Galen Growth | Insights You Can Trust, which will be released today! 💌 #HTF2023 #HealthTech50

Hot 🔥 off the press 📰 New funds are on their way to the Aussie & APAC #healthtech #deeptech ecosystems! Here's the quick wrap 👀 on Synthesis Capital... Focus 🎯 Deep health tech, led by industry experts Investment Range 💸 From pre-Seed to Series A+ stages in Australia and the Asia Pacific Partnerships 🤝 Exclusive collaboration with the MedTech Actuator for deal flow Risk Management ⚖ Integration of capital with milestone-based investment scaling Fund Size 🤑 Targeting $50M+, scalable to $100M+ (initial close at $10-20M) Returns 📊 Targeting an IRR of 25%; co-investment opportunities for LPs Team 👯 Vishaal Kishore - Managing Partner Buzz Palmer - Investment Partner, Venture Development Makenzie Thomas - Portfolio Manager Tom Bentley - Investment Partner, Ecosystems & Impact Tim Macready - Lead, Investment Governance Sophy Tang Chui Na - Investment Analyst Article written by: Will Richards https://lnkd.in/gH7UMU8t

Our team Correlate Health, Inc. and fearless leader N. Gina Malak will be hosted by KiwiTech at the Angel Investors Panel on May 21st from 02:00 PM to 03:30 PM ET. We'd love to see you there! Please feel free to share this link with others. #investors #investing #startup #digital #healthcare #womanowned #womenownedbusinesses #technology #womenshealthcare #research #researchanddevelopment #clinicaltrials

🚀 A Conversation on Enabling Healthcare Innovation with Venture Capital: I recently had the privilege to welcome Nicole Graner from the Süddeutsche Zeitung at our YZR Capital headquarters. Article in 1st comment. Tldr: 🔎 Critical need for venture capital in fostering healthcare innovation. 🔎 How our expertise-driven approach is making a difference. 🔎 My journey as a physician, entrepreneur and investor, always deeply intertwined with my passion for #healthtech. 💡 That's why: alongside Markus Feuerecker I co-founded YZR Capital with a clear vision: to propel European healthtech startups into global leadership positions. 💡 We strongly believe that our team’s expertise in health is key to supporting founders who are dedicated to change the European healthtech ecosystem. ✔ Apparently our name is difficult to pronounce – for everyone who is still wondering, it’s “wise” with an R at the end ;) -> Thanks again to Nicole - it was a pleasure! And thanks to the fantastic team at YZR Capital - Christina Schmidt, Paul Epple, Urs Keller, Holger Ebersberger, Elmar Willebrand, Michael Dr. Bitzer. #HealthTech #VentureCapital #Innovation

Dive into the dynamics of Poland's VC landscape where 2023 saw a dip to €466M, yet a promising rebound awaits in 2024, cheered by ElevenLabs' unicorn status and a healthcare innovation surge. #VC #Poland #ElevenLabs #Startups #Innovation #HealthcareTech